152 related articles for article (PubMed ID: 26305676)
1. ZIP4 silencing improves bone loss in pancreatic cancer.
Zhang Q; Sun X; Yang J; Ding H; LeBrun D; Ding K; Houchen CW; Postier RG; Ambrose CG; Li Z; Bi X; Li M
Oncotarget; 2015 Sep; 6(28):26041-51. PubMed ID: 26305676
[TBL] [Abstract][Full Text] [Related]
2. ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells.
Yang J; Zhang Z; Zhang Y; Ni X; Zhang G; Cui X; Liu M; Xu C; Zhang Q; Zhu H; Yan J; Zhu VF; Luo Y; Hagan JP; Li Z; Fang J; Jatoi A; Fernandez-Zapico ME; Zheng L; Edil BH; Bronze MS; Houchen CW; Li YP; Li M
Gastroenterology; 2019 Feb; 156(3):722-734.e6. PubMed ID: 30342032
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts.
Li M; Zhang Y; Bharadwaj U; Zhai QJ; Ahern CH; Fisher WE; Brunicardi FC; Logsdon CD; Chen C; Yao Q
Clin Cancer Res; 2009 Oct; 15(19):5993-6001. PubMed ID: 19755388
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression.
Li M; Zhang Y; Liu Z; Bharadwaj U; Wang H; Wang X; Zhang S; Liuzzi JP; Chang SM; Cousins RJ; Fisher WE; Brunicardi FC; Logsdon CD; Chen C; Yao Q
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18636-41. PubMed ID: 18003899
[TBL] [Abstract][Full Text] [Related]
5. ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer.
Cui X; Zhang Y; Yang J; Sun X; Hagan JP; Guha S; Li M
Cell Cycle; 2014; 13(7):1180-6. PubMed ID: 24553114
[TBL] [Abstract][Full Text] [Related]
6. ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts.
Zhang Y; Chen C; Yao Q; Li M
Cancer Biol Ther; 2010 Feb; 9(3):236-42. PubMed ID: 20023433
[TBL] [Abstract][Full Text] [Related]
7. ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB.
Zhang Y; Bharadwaj U; Logsdon CD; Chen C; Yao Q; Li M
Clin Cancer Res; 2010 Mar; 16(5):1423-30. PubMed ID: 20160059
[TBL] [Abstract][Full Text] [Related]
8. ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism.
Liu M; Yang J; Zhang Y; Zhou Z; Cui X; Zhang L; Fung KM; Zheng W; Allard FD; Yee EU; Ding K; Wu H; Liang Z; Zheng L; Fernandez-Zapico ME; Li YP; Bronze MS; Morris KT; Postier RG; Houchen CW; Yang J; Li M
Clin Cancer Res; 2018 Jul; 24(13):3186-3196. PubMed ID: 29615456
[No Abstract] [Full Text] [Related]
9. Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer.
Zhou Z; Ren Y; Yang J; Liu M; Shi X; Luo W; Fung KM; Xu C; Bronze MS; Zhang Y; Houchen CW; Li M
Gastroenterology; 2022 Nov; 163(5):1281-1293.e1. PubMed ID: 35777482
[TBL] [Abstract][Full Text] [Related]
10. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways.
Zheng Y; Chow SO; Boernert K; Basel D; Mikuscheva A; Kim S; Fong-Yee C; Trivedi T; Buttgereit F; Sutherland RL; Dunstan CR; Zhou H; Seibel MJ
J Bone Miner Res; 2014 Sep; 29(9):1938-49. PubMed ID: 24676805
[TBL] [Abstract][Full Text] [Related]
11. Clinical prognostic significance and pro-metastatic activity of RANK/RANKL via the AKT pathway in endometrial cancer.
Wang J; Liu Y; Wang L; Sun X; Wang Y
Oncotarget; 2016 Feb; 7(5):5564-75. PubMed ID: 26734994
[TBL] [Abstract][Full Text] [Related]
12. Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.
Virk MS; Petrigliano FA; Liu NQ; Chatziioannou AF; Stout D; Kang CO; Dougall WC; Lieberman JR
Bone; 2009 Jan; 44(1):160-7. PubMed ID: 18929692
[TBL] [Abstract][Full Text] [Related]
13. The ZIP4 pathway in pancreatic cancer.
Donahue T; Hines OJ
Cancer Biol Ther; 2010 Feb; 9(3):243-5. PubMed ID: 20104017
[No Abstract] [Full Text] [Related]
14. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
16. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
Thouverey C; Caverzasio J
Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
Liu W; Zhang X
Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
[TBL] [Abstract][Full Text] [Related]
18. The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss.
Zappitelli T; Chen F; Moreno L; Zirngibl RA; Grynpas M; Henderson JE; Aubin JE
J Bone Miner Res; 2013 Nov; 28(11):2400-13. PubMed ID: 23606335
[TBL] [Abstract][Full Text] [Related]
19. Zip4 (Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration.
Weaver BP; Zhang Y; Hiscox S; Guo GL; Apte U; Taylor KM; Sheline CT; Wang L; Andrews GK
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957146
[TBL] [Abstract][Full Text] [Related]
20. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer.
Jin H; Liu P; Wu Y; Meng X; Wu M; Han J; Tan X
Cancer Sci; 2018 Sep; 109(9):2946-2956. PubMed ID: 30007115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
